Sibannac, Inc. (OTCID:SNNC) Enters Into Non-Binding Letter of Intent for Strategic Collaboration and Potential Reverse Merger Focused on Advancing Patient Health Potential

Sibannac, Inc. Announces Development of Functional Mushroom Products and Moringa to Expand Wellness Portfolio

Sibannac, Inc. (SNNC) Announces Joint Venture With 1120 Management, LLC to Develop State-of-the-Art DEA-Compliant Psilocybin Research Facility in Phoenix, Arizona

Sibannac, Inc. Anticipates Surge In Psychedelic Tourism Following Presidential Executive Order Fast-Tracking Reserarch

Sibannac, Inc. (OTC:SNNC) Announces Strategic Marketing & Revenue Acceleration Partnership With Small Cap Access

Sibannac, Inc. Begins Taking Reservations For Its Ayahuasca Retreat At World-Renowned Rythmia In Costa Rica

Sibannac, Inc. Announces Its Inaugural Plant Medicine Retreat At Rythmia In Costa Rica

Sibannac, Inc. and 4biddenknowledge Forge Strategic Partnership to Accelerate Global Psychedelic Retreats

Sibannac, Inc. and 4biddenknowledge, Inc. Record First Podcast in Planned Series

Sibannac, Inc. and 4biddenknowledge, Inc. Announce Co-Marketing Partnership to Launch Podcasts, Plant-Medicine Retreats, and Innovative Wellness Products

Sibannac, Inc. Announces Luxury Plant-Based Wellness Tourism with U.S. and International Retreats

Sibannac Expands into Booming $1.4 Trillion Wellness Tourism Market with Starwalker Journeys

Sibannac Launches Starwalker Cafe - A Transformational Hub for Consciousness Exploration, Wellness Journeys, and Lifestyle Growth

Sibannac, Inc. and Higher Times Announce Strategic Joint Venture to Expand Consciousness and Wellness Project Offerings

SIBANNAC, INC. RETURNS 102,233,482 RESERVED SHARES BACK TO THE TREASURY

SIBANNAC, INC. LAUNCHES THE CAMPUS CO.

SIBANNAC, INC. PROVIDES UPDATE TO SHAREHOLDERS

SIBANNAC, INC. ANNOUNCES ENTRY INTO MEMORANDUM OF UNDERSTANDING TO ACQUIRE STELLAR CHEMICAL CORP.